{"count":11,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/12e75bdc-39a5-417e-8549-cb7b712f69ae/","filing_uuid":"12e75bdc-39a5-417e-8549-cb7b712f69ae","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/12e75bdc-39a5-417e-8549-cb7b712f69ae/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-04-20T15:55:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to data privacy standards and transparency; and Issues related to right to repair for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304 / S. S587 / H. Rept. 119-271 / S. Rept. 117-55 - Labor-HHS-Education Appropriation Act, FY 2026;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82e28d86-ef96-436b-94df-bdc62fe5ac81/","filing_uuid":"82e28d86-ef96-436b-94df-bdc62fe5ac81","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82e28d86-ef96-436b-94df-bdc62fe5ac81/print/","filing_document_content_type":"text/html","income":null,"expenses":"1240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-07-20T09:22:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/799e5a99-25ab-4e63-ab62-1b4c5261b642/","filing_uuid":"799e5a99-25ab-4e63-ab62-1b4c5261b642","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/799e5a99-25ab-4e63-ab62-1b4c5261b642/print/","filing_document_content_type":"text/html","income":null,"expenses":"860000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-07-20T16:14:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 8646 / H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/fe224026-752b-4216-882e-88cc8518f2ee/","filing_uuid":"fe224026-752b-4216-882e-88cc8518f2ee","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/fe224026-752b-4216-882e-88cc8518f2ee/print/","filing_document_content_type":"text/html","income":null,"expenses":"1790000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-10-19T15:50:22-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Colorectal Cancer Early Detection Act, H.R. 5162, S. 5287. This bill will authorize the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to make grants to States to increase awareness and education for colorectal cancer and improve early detection of colorectal cancer. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, S.2024/H.R.3907. This bill would extend funding for the Marketplace navigator program. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act, H.R.9877, S.5066. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839, S.5052. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. Harley Jacobson Clinical Trial Participant Income Exemption Act, H.R. 4184, S.5127. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. Harley Jacobsen Clinical Trial Participant Income Exemption Act, S.5127, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178, S.4566. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP). Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act, H.R.10068, S.5312. This bill requires CDC to develop a strategy and carry out a specific initiative to prevent and reduce the use of electronic cigarettes and emerging tobacco products among youth and young adults. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC and OSH funding, and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 House and Senate Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars s and cessation therapies as well as language to reduce drug shortages and fully implement FDORA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 House and Senate Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280, S.3607. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178, S.4566. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. Harley Jacobsen Clinical Trial Participant Income Exemption Act, S.5127, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Indian Health Services. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8aa76a1c-844e-4c06-ae85-982473e899d8/","filing_uuid":"8aa76a1c-844e-4c06-ae85-982473e899d8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8aa76a1c-844e-4c06-ae85-982473e899d8/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-10-20T14:08:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027; HR 6500, Continuing Appropriations and Extensions Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning; S1072 Stop California from Advancing Regulatory Burden Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; HR 1449 Energy Resilient Communities Act; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 Stop CARB Act of 2025; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; HR 5437 Protection of Lawful Commerce in Stone Slab Products Act; H.R. 4626 Home Appliance Protection and Affordability Act; H.R. 4758 Homeowner Energy Freedom Act; H.R. 7977 Energy Bills Relief Act; H.R. 7821 Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; H.R. 4593 SHOWER Act; H.R. 5184 Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; HR 9243/S 4732, Wildfire Smoke Emergency Declaration Act; HR 9453/S 4931, End EPA Abuse Act;HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 2027; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; S 4404, No Passes for Polluters Act; S 5045, Wildfire Emissions Prevention Act; HR 9019, POWER Act; S 5092, Restoring Affordability in Automobile Manufacturing; S. 5311, Cabin Air Safety Act; S 5215, Cleaner Transportation Access for All; HR 10065, Methane Polluter Accountability Act; S5338, Energy Efficiency Reform Act; HR 10154, Protect America from CARB Act; HJ Res 202, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; HJ Res 211, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 206, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 207, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Conformation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years\"; HJ Res 212, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; SJ Res 208, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; HJ Res 214, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision\"; SJ Res 205, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision; HJ Res 210, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\".; SJ Res 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\"; HJ Res 213, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to the \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; SJ Res 210, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; S. 5653, Bipartisan American Affordability and Jobs Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act; S. 5428, Stop the Wait Act of 2026; H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025; S. 1157 Women and Lung Cancer Research and Preventive Services Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; issues related to implementation of P.L. 119-21, One Big Beautiful Bill Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act; S. 5428, Stop the Wait Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; H.R. 10068, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; S. 5312, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8aa76a1c-844e-4c06-ae85-982473e899d8/","filing_uuid":"8aa76a1c-844e-4c06-ae85-982473e899d8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8aa76a1c-844e-4c06-ae85-982473e899d8/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-10-20T14:08:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027; HR 6500, Continuing Appropriations and Extensions Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning; S1072 Stop California from Advancing Regulatory Burden Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; HR 1449 Energy Resilient Communities Act; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 Stop CARB Act of 2025; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; HR 5437 Protection of Lawful Commerce in Stone Slab Products Act; H.R. 4626 Home Appliance Protection and Affordability Act; H.R. 4758 Homeowner Energy Freedom Act; H.R. 7977 Energy Bills Relief Act; H.R. 7821 Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; H.R. 4593 SHOWER Act; H.R. 5184 Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; HR 9243/S 4732, Wildfire Smoke Emergency Declaration Act; HR 9453/S 4931, End EPA Abuse Act;HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 2027; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; S 4404, No Passes for Polluters Act; S 5045, Wildfire Emissions Prevention Act; HR 9019, POWER Act; S 5092, Restoring Affordability in Automobile Manufacturing; S. 5311, Cabin Air Safety Act; S 5215, Cleaner Transportation Access for All; HR 10065, Methane Polluter Accountability Act; S5338, Energy Efficiency Reform Act; HR 10154, Protect America from CARB Act; HJ Res 202, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; HJ Res 211, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 206, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's 2009 and Subsequent Model Year Greenhouse Gas Emission Standards for New Motor Vehicles\"; SJ Res 207, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Conformation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years\"; HJ Res 212, Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; SJ Res 208, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Motor Vehicle Pollution Control Standards; Advanced Clean Car Program; Reconsideration of a Previous Withdrawal of a Waiver of Preemption; Notice of Decision\"; HJ Res 214, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision\"; SJ Res 205, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Small Off-Road Engines Regulations; Notice of Decision; HJ Res 210, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\".; SJ Res 209, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision\"; HJ Res 213, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to the \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; SJ Res 210, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating \"California State Nonroad Engine Pollution Control Standards; Commercial Harbor Craft Regulations; Notice of Decision\"; S. 5653, Bipartisan American Affordability and Jobs Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act; S. 5428, Stop the Wait Act of 2026; H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025; S. 1157 Women and Lung Cancer Research and Preventive Services Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; issues related to implementation of P.L. 119-21, One Big Beautiful Bill Act; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act; S. 5428, Stop the Wait Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; H.R. 10068, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; S. 5312, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S 317 Charitable Act; HR 801 Charitable Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY26 appropriations; Issues relating to FY27 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cc13e5b6-b8c1-4187-a830-d1977f4fde8e/","filing_uuid":"cc13e5b6-b8c1-4187-a830-d1977f4fde8e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/cc13e5b6-b8c1-4187-a830-d1977f4fde8e/print/","filing_document_content_type":"text/html","income":null,"expenses":"510000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-10-20T17:22:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Artificial Intelligence, cybersecurity and data for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to medical supply chain resiliency and procurement; and Issues related to access to artificial intelligence models.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to medical supply chain resiliency and procurement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}